A comprehensive view of glaxosmithkline plc (gsk). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

COVID-19 vaccine makers prepare for smaller booster vaccine market as demand for first shots falls; global booster shot market, including people over 50, adults with health risk factors or who work in high-risk occupations, estimated at 1.7 billion people
Published: May 10, 2022 by CE Noticias Financieras
GlaxoSmithKline reports Q1 GAAP net profit up 68% from a year ago to £1.8B, with total turnover up 32% year-over-year to £9.8B; specialty medicines up 98% year-over-year as COVID-19 drug Xevudy sotrovimab sales hit £1.3B, vaccines up 36% year-over year
Published: May 03, 2022 by SeeNews Pharmaceuticals
GSK acquires Sierra Oncology and its developmental momelotinib myelofibrosis treatment for US$1.9B, with deal closing in Q3; momelotinib currently in clinical trials to treat myelofibrosis patients with anemia, which affects 20,000 patients in US
Published: April 27, 2022 by GlaxoSmithKline PLC (GSK)
GSK Consumer Healthcare launches Sensodyne Nourish, a new range of toothpaste with bio-active minerals; brand partners with Queer Eye star Bobby Berk, National Recreation and Park Assn. for #ActsOfNourish environmental campaign to support product launch
Published: April 19, 2022 by PR Newswire
GSK appoints six directors to the designate board of Haleon, the new independent company to be formed by spinoff of GSK Consumer Healthcare business
Published: March 15, 2022 by GlaxoSmithKline PLC

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count